[ Price : $8.95]
FDA removes partial clinical hold against MacroGenics Phase 2 LINNET study evaluating the investigational cancer therapy lorigerli...[ Price : $8.95]
An FDA Matters column calls on FDA to fully enforce the laws against mass compounding of approved drugs that are not in shortage.[ Price : $8.95]
FDA warns Glens Falls, NY-based Medline Industries about Quality System violations in its manufacturing and assembly of cardiovasc...[ Price : $8.95]
FDA solicits applications for its new READI-Home innovation challenge to use medical technology in the home to reduce or prevent h...[ Price : $8.95]
Healthcare advocacy organizations call on key House lawmakers to hold hearings and advance bipartisan legislation aimed at lowerin...[ Price : $8.95]
FDA agrees to hear an Outlook Therapeutics formal dispute resolution request regarding the agencys prior rejection of eye disease ...[ Price : $8.95]
A federal judge declines to immediately restrict access to the abortion pill mifepristone, instead pausing a high-profile lawsuit ...[ Price : $8.95]
FDA warns Newport Beach, CA-based physician Ehsan Sadri about failing to follow the investigational plan in two clinical trials.